NM_002386.4:c.466G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002386.4(MC1R):​c.466G>C​(p.Val156Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000835 in 1,606,168 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V156A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0047 ( 4 hom., cov: 33)
Exomes 𝑓: 0.00043 ( 7 hom. )

Consequence

MC1R
NM_002386.4 missense

Scores

5
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.18

Publications

13 publications found
Variant links:
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00790441).
BP6
Variant 16-89919724-G-C is Benign according to our data. Variant chr16-89919724-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 258651.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-89919724-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 258651.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-89919724-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 258651.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-89919724-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 258651.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-89919724-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 258651.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-89919724-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 258651.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00468 (713/152360) while in subpopulation AFR AF = 0.0167 (695/41590). AF 95% confidence interval is 0.0157. There are 4 homozygotes in GnomAd4. There are 327 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 713 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MC1RNM_002386.4 linkc.466G>C p.Val156Leu missense_variant Exon 1 of 1 ENST00000555147.2 NP_002377.4 Q01726Q1JUL4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MC1RENST00000555147.2 linkc.466G>C p.Val156Leu missense_variant Exon 1 of 1 6 NM_002386.4 ENSP00000451605.1 Q01726
ENSG00000198211ENST00000556922.1 linkc.466G>C p.Val156Leu missense_variant Exon 1 of 5 2 ENSP00000451560.1 A0A0B4J269

Frequencies

GnomAD3 genomes
AF:
0.00467
AC:
711
AN:
152242
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0167
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00111
AC:
269
AN:
241902
AF XY:
0.000932
show subpopulations
Gnomad AFR exome
AF:
0.0166
Gnomad AMR exome
AF:
0.000232
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000180
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000432
AC:
628
AN:
1453808
Hom.:
7
Cov.:
34
AF XY:
0.000350
AC XY:
253
AN XY:
723576
show subpopulations
African (AFR)
AF:
0.0168
AC:
564
AN:
33474
American (AMR)
AF:
0.000380
AC:
17
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45732
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000720
AC:
8
AN:
1111768
Other (OTH)
AF:
0.000647
AC:
39
AN:
60308
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
45
89
134
178
223
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00468
AC:
713
AN:
152360
Hom.:
4
Cov.:
33
AF XY:
0.00439
AC XY:
327
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.0167
AC:
695
AN:
41590
American (AMR)
AF:
0.000784
AC:
12
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68036
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
42
83
125
166
208
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000272
Hom.:
0
Bravo
AF:
0.00552
ESP6500AA
AF:
0.0187
AC:
82
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00138
AC:
167
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Melanoma, cutaneous malignant, susceptibility to, 5 Benign:2
Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jun 11, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32163215, 23647022) -

Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MC1R: BP4, BS1, BS2 -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tyrosinase-positive oculocutaneous albinism;C1849452:SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2;C2751295:Melanoma, cutaneous malignant, susceptibility to, 5;C2751296:Increased analgesia from kappa-opioid receptor agonist, female-specific Benign:1
Mar 27, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
14
DANN
Uncertain
0.98
DEOGEN2
Benign
0.066
.;T;T;.
Eigen
Benign
-0.42
Eigen_PC
Benign
-0.44
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.97
D;.;D;D
MetaRNN
Benign
0.0079
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.7
.;L;L;.
PhyloP100
2.2
PROVEAN
Benign
-0.25
N;.;N;N
REVEL
Benign
0.081
Sift
Uncertain
0.0010
D;.;D;D
Sift4G
Uncertain
0.019
D;.;D;D
Polyphen
0.57
.;P;P;.
Vest4
0.35
MutPred
0.25
Loss of MoRF binding (P = 0.1166);Loss of MoRF binding (P = 0.1166);Loss of MoRF binding (P = 0.1166);Loss of MoRF binding (P = 0.1166);
MVP
0.28
MPC
0.061
ClinPred
0.059
T
GERP RS
1.8
Varity_R
0.17
gMVP
0.22
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3212365; hg19: chr16-89986132; COSMIC: COSV59625284; COSMIC: COSV59625284; API